Optimization of Treatment and Management of Schizophrenia in Europe (OPTIMISE): Substudy Site Copenhagen

NCT01555814 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

56

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia
Schizophreniform Disorder
Schizoaffective Disorder

Interventions

DRUG: Amisulpride

Sponsor

Birte Glenthoj

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]